Transcription-coupled repair deficiency and mutations in human mismatch repair genes.

PubWeight™: 1.73‹?› | Rank: Top 3%

🔗 View Article (PMID 8614807)

Published in Science on April 26, 1996

Authors

I Mellon1, D K Rajpal, M Koi, C R Boland, G N Champe

Author Affiliations

1: Department of Pathology, Program in Toxicology, Markey Cancer Center, University of Kentucky, Lexington, KY 40536, USA.

Articles citing this

BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev (2000) 7.29

Mismatch repair proficiency and in vitro response to 5-fluorouracil. Gastroenterology (1999) 3.06

Negative regulation of mutS and mutH repair gene expression by the Hfq and RpoS global regulators of Escherichia coli K-12. J Bacteriol (1997) 2.69

DNA mismatch repair: molecular mechanism, cancer, and ageing. Mech Ageing Dev (2008) 2.40

Recognition and repair of compound DNA lesions (base damage and mismatch) by human mismatch repair and excision repair systems. Mol Cell Biol (1997) 1.79

hMutSalpha- and hMutLalpha-dependent phosphorylation of p53 in response to DNA methylator damage. Proc Natl Acad Sci U S A (1999) 1.63

Replication errors: cha(lle)nging the genome. EMBO J (1998) 1.62

Elevated levels of mutation in multiple tissues of mice deficient in the DNA mismatch repair gene Pms2. Proc Natl Acad Sci U S A (1997) 1.51

Cockayne syndrome group B cellular and biochemical functions. Am J Hum Genet (2003) 1.46

Mouse embryonic stem cells carrying one or two defective Msh2 alleles respond abnormally to oxidative stress inflicted by low-level radiation. Proc Natl Acad Sci U S A (1998) 1.45

Differential human nucleotide excision repair of paired and mispaired cisplatin-DNA adducts. Nucleic Acids Res (1997) 1.38

ATR functions as a gene dosage-dependent tumor suppressor on a mismatch repair-deficient background. EMBO J (2004) 1.36

Mismatch repair proteins are activators of toxic responses to chromium-DNA damage. Mol Cell Biol (2005) 1.32

Different mutator phenotypes in Mlh1- versus Pms2-deficient mice. Proc Natl Acad Sci U S A (1999) 1.32

Strand bias in targeted gene repair is influenced by transcriptional activity. Mol Cell Biol (2002) 1.29

Different mismatch repair deficiencies all have the same effects on somatic hypermutation: intact primary mechanism accompanied by secondary modifications. J Exp Med (1999) 1.28

Concerted evolution of the tandemly repeated genes encoding human U2 snRNA (the RNU2 locus) involves rapid intrachromosomal homogenization and rare interchromosomal gene conversion. EMBO J (1997) 1.25

Physical interaction between components of DNA mismatch repair and nucleotide excision repair. Proc Natl Acad Sci U S A (1998) 1.24

Translocation of Cockayne syndrome group A protein to the nuclear matrix: possible relevance to transcription-coupled DNA repair. Proc Natl Acad Sci U S A (2002) 1.19

Risk of childhood leukemia associated with diagnostic irradiation and polymorphisms in DNA repair genes. Environ Health Perspect (2000) 1.13

Mismatch repair processing of carcinogen-DNA adducts triggers apoptosis. Mol Cell Biol (1999) 1.12

The mismatch repair protein MSH2 is rate limiting for repeat expansion in a fragile X premutation mouse model. Hum Mutat (2014) 1.07

Single-molecule FRET TACKLE reveals highly dynamic mismatched DNA-MutS complexes. Biochemistry (2010) 1.04

Transcription affects formation and processing of intermediates in oligonucleotide-mediated gene alteration. Nucleic Acids Res (2003) 1.02

The uvrA, uvrB and uvrC genes are required for repair of ultraviolet light induced DNA photoproducts in Halobacterium sp. NRC-1. Saline Systems (2006) 1.02

Folate depletion impairs DNA excision repair in the colon of the rat. Gut (1998) 1.02

The role of the human DNA mismatch repair gene hMSH2 in DNA repair, cell cycle control and apoptosis: implications for pathogenesis, progression and therapy of cancer. J Mol Histol (2006) 0.91

Frequent loss of heterozygosity at the DNA mismatch-repair loci hMLH1 and hMSH3 in sporadic breast cancer. Br J Cancer (1999) 0.90

Protective actions of vitamin D in UVB induced skin cancer. Photochem Photobiol Sci (2012) 0.88

Inhibition of generation of authentic genomic termini of herpes simplex virus type 1 DNA in temperature-sensitive mutant BHK-21 cells with a mutated CCG1/TAF(II)250 gene. J Virol (1996) 0.87

Protective role of vitamin D signaling in skin cancer formation. J Steroid Biochem Mol Biol (2012) 0.87

Testicular nuclear receptor 4 (TR4) regulates UV light-induced responses via Cockayne syndrome B protein-mediated transcription-coupled DNA repair. J Biol Chem (2011) 0.87

Transcription and DNA damage: a link to a kink. Environ Health Perspect (1997) 0.86

Mismatch repair mutants in yeast are not defective in transcription-coupled DNA repair of UV-induced DNA damage. Genetics (1996) 0.84

Loss of heterozygosity is related to p53 mutations and smoking in lung cancer. Br J Cancer (2001) 0.84

hMSH2 expression is driven by AP1-dependent regulation through phorbol-ester exposure. Nucleic Acids Res (2003) 0.84

Antagonism of ultraviolet-light mutagenesis by the methyl-directed mismatch-repair system of Escherichia coli. Genetics (2000) 0.83

Isolation of human complexes proficient in nucleotide excision repair. Nucleic Acids Res (1997) 0.83

MiR-21: an environmental driver of malignant melanoma? J Transl Med (2015) 0.82

A seven-gene CpG-island methylation panel predicts breast cancer progression. BMC Cancer (2015) 0.82

MutLα heterodimers modify the molecular phenotype of Friedreich ataxia. PLoS One (2014) 0.81

Implication of localization of human DNA repair enzyme O6-methylguanine-DNA methyltransferase at active transcription sites in transcription-repair coupling of the mutagenic O6-methylguanine lesion. Mol Cell Biol (1998) 0.81

Functional nucleotide excision repair is required for the preferential removal of N-ethylpurines from the transcribed strand of the dihydrofolate reductase gene of Chinese hamster ovary cells. Mol Cell Biol (1997) 0.80

Global genome removal of thymine glycol in Escherichia coli requires endonuclease III but the persistence of processed repair intermediates rather than thymine glycol correlates with cellular sensitivity to high doses of hydrogen peroxide. Nucleic Acids Res (2002) 0.79

Identification of cancer predisposition variants in apparently healthy individuals using a next-generation sequencing-based family genomics approach. Hum Genomics (2015) 0.79

New insights and challenges in mismatch repair: getting over the chromatin hurdle. DNA Repair (Amst) (2014) 0.78

Influence of Helicobacter pylori infection on the expression of MLH1 and MGMT in patients with chronic gastritis and gastric cancer. Eur J Clin Microbiol Infect Dis (2008) 0.77

Transcription-coupled repair is inducible in hamster cells. Nucleic Acids Res (2000) 0.75

A tale of two cities: A tribute to Aziz Sancar's Nobel Prize in Chemistry for his molecular characterization of NER. DNA Repair (Amst) (2016) 0.75

Clement Richard Boland, Jr., MD: a conversation with the editor. Interview by William Clifford Roberts. Proc (Bayl Univ Med Cent) (2004) 0.75

Crosstalk between MSH2-MSH3 and polβ promotes trinucleotide repeat expansion during base excision repair. Nat Commun (2016) 0.75

Close encounters: Moving along bumps, breaks, and bubbles on expanded trinucleotide tracts. DNA Repair (Amst) (2017) 0.75

Articles by these authors

A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst (1997) 5.68

Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet (2009) 3.99

Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology (1993) 3.76

Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N'-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Res (1994) 3.63

Conversion of diploidy to haploidy. Nature (2000) 3.28

Mismatch repair proficiency and in vitro response to 5-fluorouracil. Gastroenterology (1999) 3.06

DNA repair and colorectal cancer. Gastroenterol Clin North Am (1996) 2.88

Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst (1995) 2.62

Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res (1996) 2.37

BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells. Br J Cancer (2003) 2.26

Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint. Cancer Res (1995) 2.17

Alterations in human colonic mucin occurring with cellular differentiation and malignant transformation. Proc Natl Acad Sci U S A (1982) 2.17

Specificity of DNA lesion bypass by the yeast DNA polymerase eta. J Biol Chem (2000) 2.12

JC virus DNA is present in the mucosa of the human colon and in colorectal cancers. Proc Natl Acad Sci U S A (1999) 2.08

Correction of hypermutability, N-methyl-N'-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6. Cancer Res (1997) 1.96

Prognostic significance of allelic lost at chromosome 18q21 for stage II colorectal cancer. Gastroenterology (1998) 1.90

Computational drug repositioning: from data to therapeutics. Clin Pharmacol Ther (2013) 1.82

Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res (1996) 1.74

Genetic pathways in the evolution of morphologically distinct colorectal neoplasms. Cancer Res (2001) 1.70

JC virus DNA sequences are frequently present in the human upper and lower gastrointestinal tract. Gastroenterology (2000) 1.68

Steady-state regulation of the human DNA mismatch repair system. J Biol Chem (2000) 1.66

JC virus infects the enteric glia of patients with chronic idiopathic intestinal pseudo-obstruction. Gut (2008) 1.59

Products of DNA mismatch repair genes mutS and mutL are required for transcription-coupled nucleotide-excision repair of the lactose operon in Escherichia coli. Proc Natl Acad Sci U S A (1996) 1.58

Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N'-nitro-N-nitrosoguanidine. J Clin Invest (1996) 1.49

Regulation of canine gastric mucin synthesis and phospholipid secretion by acid secretagogues. Gastroenterology (1992) 1.46

Human DNA polymerase kappa synthesizes DNA with extraordinarily low fidelity. Nucleic Acids Res (2000) 1.41

Suppression of human colorectal mucosal prostaglandins: determining the lowest effective aspirin dose. J Natl Cancer Inst (1997) 1.40

Translesion synthesis by yeast DNA polymerase zeta from templates containing lesions of ultraviolet radiation and acetylaminofluorene. Nucleic Acids Res (2001) 1.37

Mad-1 is the exclusive JC virus strain present in the human colon, and its transcriptional control region has a deleted 98-base-pair sequence in colon cancer tissues. J Virol (2001) 1.36

Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett (2001) 1.33

A cancer-associated mucin alteration in benign colonic polyps. Gastroenterology (1982) 1.33

Induction of cellular senescence in immortalized cells by human chromosome 1. Science (1990) 1.31

Wilms tumor locus on 11p13 defined by multiple CpG island-associated transcripts. Science (1990) 1.28

Oxidative stress increases frameshift mutations in human colorectal cancer cells. Cancer Res (2001) 1.28

Abnormal goblet cell glycoconjugates in rectal biopsies associated with an increased risk of neoplasia in patients with ulcerative colitis: early results of a prospective study. Gut (1984) 1.26

Defective expression of the DNA mismatch repair protein, MLH1, alters G2-M cell cycle checkpoint arrest following ionizing radiation. Cancer Res (1998) 1.22

Familial colonic cancer without antecedent polyposis. Ann Intern Med (1984) 1.21

Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro. Br J Cancer (2003) 1.21

Transforming growth factor alpha protection against drug-induced injury to the rat gastric mucosa in vivo. J Clin Invest (1992) 1.15

Restoration of radiation resistance in ataxia telangiectasia cells by the introduction of normal human chromosome 11. Mutat Res (1990) 1.15

The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative study. Fam Cancer (2001) 1.13

Complementation of an hMSH2 defect in human colorectal carcinoma cells by human chromosome 2 transfer. Mol Carcinog (2000) 1.12

Post-translational processing of gastrin in neoplastic human colonic tissues. Biochem Biophys Res Commun (1992) 1.12

Expression of human MutS homolog 2 (hMSH2) protein in resting and proliferating cells. Oncogene (1996) 1.08

Microsatellites in the eukaryotic DNA mismatch repair genes as modulators of evolutionary mutation rate. Genome Res (2001) 1.07

Comparison of T-antigen expression in normal, premalignant, and malignant human colonic tissue using lectin and antibody immunohistochemistry. Cancer Res (1986) 1.06

The effects of omeprazole and famotidine on mucin and PGE2 release in the rat stomach. Aliment Pharmacol Ther (1996) 1.05

Limited up-regulation of DNA methyltransferase in human colon cancer reflecting increased cell proliferation. Proc Natl Acad Sci U S A (1996) 1.05

Colonic mucosal prostaglandin E2 and cyclooxygenase expression before and after low aspirin doses in subjects at high risk or at normal risk for colorectal cancer. Cancer Epidemiol Biomarkers Prev (2001) 1.04

Mucormycoma of the colon: early diagnosis and successful management. AJR Am J Roentgenol (1985) 1.03

A change in microsatellite instability caused by cisplatin-based chemotherapy of ovarian cancer. Br J Cancer (2001) 1.02

Transfer of a normal human chromosome 11 suppresses tumorigenicity of some but not all tumor cell lines. J Cell Biochem (1990) 1.02

Microsatellite instability and loss of heterozygosity at DNA mismatch repair gene loci occurs during hepatic carcinogenesis. Hepatology (1998) 0.98

Loss of tumor-suppressive function during chemically induced neoplastic progression of Syrian hamster embryo cells. Proc Natl Acad Sci U S A (1986) 0.98

Glycoconjugates in the colons of New World monkeys with spontaneous colitis. Association between inflammation and neoplasia. Gastroenterology (1987) 0.97

Induction of interferon-gamma in mouse spleen cells by OK-432, a preparation of Streptococcus pyogenes. Cell Immunol (1982) 0.96

Localization of the Bannayan-Riley-Ruvalcaba syndrome gene to chromosome 10q23. Gastroenterology (1997) 0.93

Colon cancer genetics. Cancer (1992) 0.89

Regional differences in normal and cancer-associated glycoconjugates of the human colon. J Natl Cancer Inst (1985) 0.89

Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas. Genes Chromosomes Cancer (1997) 0.89

Role of oncogenes and tumor suppressor genes in a multistep model of carcinogenesis. Symp Fundam Cancer Res (1986) 0.88

Synthesis and prostaglandin E2-induced secretion of surfactant phospholipid by isolated gastric mucous cells. Gastroenterology (1991) 0.88

In vitro production of immune interferon (IFN gamma) by murine spleen cells when different sensitizing antigens are used in vivo and in vitro. Cell Immunol (1983) 0.85

Abnormalities of lectin histochemistry in familial polyposis coli and hereditary nonpolyposis colorectal cancer. Cancer (1990) 0.85

The lectin Griffonia simplicifolia I-A4 (GS I-A4) specifically recognizes terminal alpha-linked N-acetylgalactosaminyl groups and is cytotoxic to the human colon cancer cell lines LS174t and SW1116. Int J Cancer (1994) 0.85

Germline characterization of early-aged onset of hereditary non-polyposis colorectal cancer. J Pediatr (2001) 0.85

Eicosanoid production by the human gastric cancer cell line AGS and its relation to cell growth. Cancer Res (1992) 0.83

Absence of PTEN/MMAC1 germ-line mutations in sporadic Bannayan-Riley-Ruvalcaba syndrome. Cancer Res (1998) 0.83

Antisense inhibition of hMLH1 is not sufficient for loss of DNA mismatch repair function in the HCT116+chromosome 3 cell line. Clin Cancer Res (2000) 0.83

Liquid caustic ingestion. Spectrum of injury. Arch Intern Med (1980) 0.82

Binding of lectins to goblet cell mucin in malignant and premalignant colonic epithelium in the CF-1 mouse. Gastroenterology (1985) 0.81

Transitional mucosa of the colon and tumor growth factors. Med Hypotheses (1987) 0.81

Characteristics of colorectal carcinoma cells with high metastatic potential. Gastroenterology (1984) 0.80

Van-Gogh-like 2 antagonises the canonical WNT pathway and is methylated in colorectal cancers. Br J Cancer (2013) 0.80

Role of chromosome loss in ras/myc-induced Syrian hamster tumors. Cancer Res (1988) 0.80

Lactate dehydrogenase-elevating agent is responsible for interferon induction and enhancement of natural killer cell activity by inoculation of Ehrlich ascites carcinoma cells into mice. Microbiol Immunol (1981) 0.79

Complementation of mismatch repair gene defects by chromosome transfer. Mutat Res (1998) 0.79

Glycoconjugate expression in normal, metaplastic, and neoplastic human upper gastrointestinal mucosa. J Clin Invest (1987) 0.78

Simple purification of human chromosomes to homogeneity using muntjac hybrid cells. Nat Genet (1994) 0.78

Analysis of cancer-associated colonic mucin by ion-exchange chromatography: evidence for a mucin species of lower molecular charge and weight in cancer. Biochim Biophys Acta (1989) 0.78

Multiple tumor suppressor genes in multistep carcinogenesis. Tohoku J Exp Med (1992) 0.78

Cancer-associated colonic mucin in cultured human tumor cells and athymic (nude) mouse xenografts. Cancer Res (1986) 0.78

Undectable expression of hMLH1 protein in sporadic colorectal cancer with replication error phenotype. Dis Colon Rectum (1997) 0.78

Multistep progression of colorectal cancer in the setting of microsatellite instability: new details and novel insights. Gastroenterology (2001) 0.77

Increased gastroduodenal concentrations of transforming growth factor alpha in adaptation to aspirin in monkeys and rats. Gastroenterology (1996) 0.77

JC virus: a biomarker for colorectal cancer? Med Hypotheses (2002) 0.77

Rescue of targeted regions of mammalian chromosomes by in vivo recombination in yeast. Genome Res (1998) 0.77

In vivo effects of mesalazine or E. coli Nissle 1917 on microsatellite instability in ulcerative colitis. Aliment Pharmacol Ther (2009) 0.77

Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells. J Cell Physiol (2001) 0.76

Comparison between transforming growth factor alpha and epidermal growth factor in the protection of rat gastric mucosa against drug-induced injury. Ital J Gastroenterol (1994) 0.75

Gastrin and colorectal neoplasia--chicken or egg, or both? J Clin Gastroenterol (1991) 0.75

Fiber and colon cancer: the weight of the evidence. Gastroenterology (1992) 0.75

Hyperplastic polyps and colorectal cancer. Lancet (1983) 0.75

Increased tumorigenicity after differentiation of colon cancer cell line: absence of association with mucin synthesis. Gastroenterology (1994) 0.75

Mycoplasmas are responsible for interferon induction in cocultures of mouse NK-target lymphoma cells with mouse splenic lymphocytes. Microbiol Immunol (1983) 0.75